Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Evaluate Durvalumab and Tremelimumab +/- Lenvatinib in Combination With TACE in Patients With Locoregional HCC

AstraZeneca · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
hepatocellular-carcinomaliver-cancer
hepatocellular carcinoma, locoregional hcc, durvalumab, tremelimumab, lenvatinib, tace, liver cancer, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 868361
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.